Quantalum can take a biological product from concept through clinical trial, regulatory approval, manufacturing, commercialization, and into patient populations quicker and more cost-effectively than any competitor.Quantalum provides a flexible approach to meet timelines, costs, and reduce risks by specializing in planning, management, execution & analysis of Phase I-III clinical trials.Quantalum works with diverse groups of stakeholders including research sponsors, clinical investigators, patients, payers, physicians and regulators to enhance both patient and healthcare provider access, empower sales force readiness, and prepare the supply chain, distribution networks and customer support programs to ensure the successful launch and continued use of a drug.Quantalum focuses on therapeutic efficacy and takes into account patient value, experience, build up of infrastructure, proper staffing, and having the right technology services in place to create long term lasting value.Quantalum has team members, key advisors and stakeholders who have the knowledge and wherewithal to lead products into the largest patient populations available.Quantalum brings in house all required service offerings to take a product from concept to maximum delivery in patient populations.We focus on clinical excellence by prioritizing data-driven decisions to deliver value to our clients and work on small to large, complex, and multinational studiesOur integrated approach streamlines the clinical trial process and lowers costs by over 40% by leveraging clinical biostatistics, state-of-the-art technologies & our global reach.We maximize product delivery into patients through our network of wholly-owned delivery clinics set up to administer products.